Laureano Molins leads the annual gala of the Spanish Association Against Cancer (AECC)-Catalonia Against Cancer

Dr. Laureano Molins

Dr. Laureano Molins

Laureano Molins, head of Thoracic Surgery Clinic Hospital of Barcelona, ​​president of the Spanish Association Against Cancer (AECC) -Catalonia Against Cancer and full academician of the Royal European Academy of Doctors-Barcelona 1914 (RAED), presided last April 11th the Cancer Solidarity Night 2019 organized by the Catalan delegation of the AECC. The evening was presented by Vanesa Lorenzo and Bruno Oro and Manu Guix, Ramon Mirabet and Joan Manuel Serrat performed. The act was attended by 850 people, among others Quim Torra, president of the Catalan Government; Alba Vergés, Catalan Minister of Health; Laia Ortiz, Deputy for Social Rights of the Barcelona City Council; Pilar Solanes, director of the Health Program of the City of Barcelona and Candela Calle, director of the Catalan Institute of Oncology, in addition to many other personalities.

The Cancer Solidarity Night is organized annually to give value and to continue the work of the AECC-Catalonia Against Cancer, an association that works in the fight against this disease, to accompany and support those who suffer it, to be at the side of the relatives throughout the disease process, to pay attention to the socially vulnerable, to educate in health the society with prevention campaigns and promotion of healthy habits and improve the future of all of us through quality oncological research and close to the patient.

Molins warns of the lack of resources in the fight against cancer and calls for the start-up of legal mechanisms that guarantee that donation and private investment in institutions that fight this disease, public or private, don’t have the tax burden they still have. In this sense, he advocates a new Patronage law in Spain as a way to finance specific campaigns and programs. “The reform of the Patronage law, which hasn’t just arrived in Spain, is very important for companies that want to contribute in the fight against cancer.

Dr. Laureano Molins

In France, companies are deducted about 60% of contributions to causes like this, but in Spain doesn’t reach 10%”, said recently the academician in the newspaper “Expansión”.

The Spanish Association Against Cancer-Catalonia Against Cancer has set the goal of reaching 20 million euros in Catalonia for projects of R&D in the year 2020, compared to the current 18. In the whole of Spain this figure now amounts to 56 million, which allow to fully or partially cover more than 300 projects. In terms of effectiveness, Molins points out that the great challenge is that in the year 2030 a 70% survival rate will be reached among those affected by this serious disease in its most diverse affectations.